웨스트 나일 바이러스(WNV) 시장 : 제품 유형별, 투여 경로별, 유통 채널별, 지역별

West Nile Virus Market is estimated to be valued at USD 742.0 Mn in 2025 and is expected to reach USD 1,279.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.

West Nile virus (WNV) is a mosquito-borne disease that affects humans, birds, and other animals. It was first identified in the West Nile region of Uganda in 1937 and has since spread to many parts of the world, including North America, Europe, and Asia. The virus is primarily transmitted to humans through the bite of infected mosquitoes. WNV can cause a range of symptoms, from mild flu-like illness to severe neurologic diseases such as encephalitis and meningitis. While most infected individuals do not develop any symptoms, around 20% may experience fever, headache, body aches, nausea, vomiting, and rash. In rare cases, WNV can be fatal.

Market Dynamics:

The global West Nile virus market is driven by various factors. The rising incidence of WNV infections, especially in North America and Europe, is one of the primary drivers of market growth. Increasing awareness about the disease, its prevention, and diagnostics is also contributing to market expansion. For instance, according to data from the Centers for Disease Control and Prevention (CDC), the number of West Nile virus neuroinvasive disease cases reported to the national surveillance system increased from over 2000 cases in 2021 to over 2500 cases in 2022. States such as Texas, California, Louisiana, Nebraska, and Illinois witnessed the highest number of cases. The growing prevalence of the virus can be attributed to rising temperatures linked to climate change that are extending the transmission season and expanding the geographical range of mosquitoes that can spread the virus.

However, there are certain restraints hampering the growth of the market. The limited availability of effective treatments and vaccines is a major challenge in combating WNV. High costs associated with diagnosis and treatment further hinder market growth.

Despite these challenges, there are opportunities for market players to capitalize on. High growth potential in emerging economies, development of effective treatment options and rising usage of mosquito control methods presents a significant opportunity for growth. In addition, collaborations between pharmaceutical companies and research institutes can accelerate the development of innovative solutions for WNV.

Key features of the study:

• This report provides in-depth analysis of the global West Nile virus market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global West Nile virus market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Sanofi, Pfizer, GlaxoSmithKline, Merck, AstraZeneca, Johnson & Johnson, F. Hoffmann-La Roche, Novartis, Cipla, and Gilead Sciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global West Nile virus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global West Nile virus market

Detailed Segmentation:

• By Product Type:
  • Antivirals
  • Vaccines
  • Antibiotics
  • Analgesics
  • Others (Immunoglobulins and among Others)
• By Route of Administration:
  • Oral
  • Injectable
  • Topical
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • Sanofi
  • Pfizer
  • GlaxoSmithKline
  • Merck
  • AstraZeneca
  • Johnson & Johnson
  • Hoffmann-La Roche
  • Novartis
  • Cipla
  • Gilead Scienes

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global West Nile Virus Market, By Product Type
  • Global West Nile Virus Market, By Route of Administration
  • Global West Nile Virus Market, By Distribution Channel
  • Global West Nile Virus Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• Epidemiology
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global West Nile Virus Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global West Nile Virus Market, By Product Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Antivirals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Antibiotics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Analgesics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global West Nile Virus Market, By Route of Administration , 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Mn)
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Mn)

7. Global West Nile Virus Market, By Distribution Channel, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

8. Global West Nile Virus Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

• Sanofi
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
• Pfizer
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• GlaxoSmithKline
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Merck
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• AstraZeneca
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Johnson & Johnson
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• F.Hoffmann-La Roche
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Novartis
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Cipla
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Gilead Sciences
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

10. Section

• Research Methodology
• About us